Venetoclax salvage therapy in relapsed/refractory multiple myeloma

被引：3
|
作者：
Steinhardt, Maximilian J. [1 ]
Truger, Marietta [2 ]
Bittrich, Max [1 ]
Zhou, Xiang [1 ]
Noderer, Julia [1 ]
Riedhammer, Christine [1 ]
Xiao, Xianghui [1 ]
Gawlas, Sophia [1 ]
Weis, Philipp [1 ]
Eisele, Florian [1 ]
Haferlach, Claudia [2 ]
Mersi, Julia [1 ]
Waldschmidt, Johannes [1 ]
Einsele, Hermann [1 ]
Rasche, Leo [1 ,3 ]
Kortuem, K. Martin [1 ]
机构：
[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[2] MLL Munich Leukemia Lab, Munich, Germany
[3] Univ Klinikum Wurzburg, Mildred Scheel Early Career Ctr, Wurzburg, Germany
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 03期
关键词：
DEXAMETHASONE; COMBINATION;
D O I：
10.3324/haematol.2023.283472
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：979 / 981
页数：3
相关论文
共 50 条
  • [41] A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed/Refractory Multiple Myeloma
    Kambhampati, Swetha
    Galligan, Derek
    Ledergor, Guy
    Martin, Thomas G., III
    Wolf, Jeffrey
    Wong, Sandy W.
    Shah, Nina D.
    BLOOD, 2019, 134
  • [42] A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myeloma
    Kambhampati, Swetha
    Galligan, Derek
    Huang, Chiung-Yu
    Wong, Sandy
    Wolf, Jeffrey
    Martin, Thomas
    Shah, Nina
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1211 - 1219
  • [43] A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myeloma
    Kambhampati, Swetha
    Galligan, Derek
    Shah, Nina
    Wolf, Jeffrey
    Wong, Sandy
    Martin, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E261 - E261
  • [44] Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.
    Moreau, Philippe
    Chanan-Khan, Asher Alban Akmal
    Roberts, Andrew Warwick
    Agarwal, Amit
    Facon, Thierry
    Kumar, Shaji
    Touzeau, Cyrille
    Diehl, Susan
    Cordero, Jaclyn
    Ross, Jeremy A.
    Munasinghe, Wijith
    Zhu, Ming
    Salem, Ahmed H.
    Leverson, Joel
    Maciag, Paulo Cesar
    Verdugo, Maria E.
    Harrison, Simon J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed/Refractory Multiple Myeloma
    Galligan, Derek
    Shah, Nina
    Wolf, Jeffrey
    Wong, Sandy
    Abramovitz, Linda
    Donnelly, Brenn
    Narayan, Rupa
    Mannis, Gabriel
    Arora, Shagun
    Marsala, Amy
    Cerejo, Miguel
    Martin, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S339 - S339
  • [46] Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma
    Schjesvold, Fredrik
    Paiva, Bruno
    Ribrag, Vincent
    Rodriguez-Otero, Paula
    San-Miguel, Jesus F.
    Robak, Pawel
    Hansson, Markus
    Onishi, Maika
    Hamidi, Habib
    Malhi, Vikram
    Dail, Monique
    Javery, Apurva
    Ku, Grace
    Raab, Marc S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01): : E59 - E70
  • [47] A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
    Gasparetto, Cristina
    Bowles, Kristian M.
    Abdallah, Al-Ola
    Morris, Lura
    Mander, Gudrun
    Coppola, Sheryl
    Wang, Jing
    Ross, Jeremy A.
    Bueno, Orlando F.
    Arriola, Emma
    Mateos, Maria Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : 775 - 784
  • [48] Predictive Biomarkers of Response to Venetoclax in Combination with Cobimetinib in Relapsed/Refractory Multiple Myeloma (RRMM)
    Raval, Aparna
    Hamidi, Habib
    Hwang, Olivia
    Green, Cherie
    Maia, Catarina
    Lasa, Marta
    Onishi, Maika
    Rodriguez-Otero, Paula
    San-Miguel, Jesus F.
    Gallo, Jorge D.
    Paiva, Bruno
    Schjesvold, Fredrik
    BLOOD, 2020, 136
  • [49] Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: a meta-analysis
    Gao, Xiaohui
    Zeng, Hui
    Zhao, Xiaoyan
    Wu, Haibing
    Yan, Minchao
    Li, Yuan
    Zhang, Gang
    Sun, Fei
    BMC CANCER, 2023, 23 (01)
  • [50] Lovastatin as salvage immumomodulatory therapy in patients with refractory and relapsed multipla myeloma.
    Hus, M
    Grzasko, N
    Jawniak, D
    Szostek, M
    Dmoszynska, A
    BLOOD, 2005, 106 (11) : 449A - 450A
12345